F1CF58CE-2BE5-48FF-8E99-E387E2D59740Wellcome Trust MRC Cambridge Stem Cell InstituteIntramuralMC_PC_12009C008C651-F5B0-4859-A334-5F574AB6B57CMRCEXPENDITURE_ACTUAL30740868D47CDB3-F993-4C79-B8FE-029A8B1EF195SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness.Scientific reportscf22986a9738e491e47ede2f9915e0c9Nguyen CH2019-01-01http://dx.doi.org/10.1038/s41598-019-45579-031235852http://ukpmc.ac.uk/abstract/MED/312358522045-2322http://europepmc.org/abstract/MED/3123585291Journal Article/Review5e5d0b8f2e1b44.80133020